Can weight loss drugs curb more than appetite?
CBS News chief medical correspondent Dr. Jon LaPook takes a look at new research that suggests popular drugs like Ozempic and Wegovy might help with other cravings.
Weight Loss
Could weight loss drugs curb other addictions?
A group of weight loss and diabetes treatment drugs, known as GLP-1 agonists, work by curbing appetite centers in the brain. But animal studies suggest these drugs could also potentially reduce addiction to nicotine, alcohol, and opioids. Dr. Jon LaPook explains.
South Korean officials say Kim Jong Un regains weight, fueling health woes
North Korean dictator Kim Jong Un has regained weight and his 5-foot 7-inch, 308-pound stature is exacerbating health problems, South Korean officials say.
Drugs used for weight loss help people stop smoking, study finds
Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking.
Why millions are trying FDA-approved alternatives to Big Pharma's weight loss drugs
Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they object to specialty pharmacies making their own cheaper versions to fill the gap — providing as much as 30% of those drugs sold in the U.S.
Wrist weights are a trendy hack for toned arms, but are they safe?
A workout that mindlessly tones your arms while getting some cardio in? If it sounds too good to be true, that's because it may be. Here's what experts say.
Ozempic craze can trigger complicated feelings for those who wished for "magic fix"
Even if someone has gone through a healing process with body image or their relationship with food, these challenges can "last a lifetime," a licensed mental health counselor tells CBS News.
1/1/2023: Radio Free Europe, The Vanishing Wild, Obesity
Radio Free Europe's return to prominence in Russia and former Soviet territories; Earth currently experiencing a sixth mass extinction, according to scientists; Promising new weight loss medication in short supply and often not covered by insurance.
Are enough doctors trained on obesity drugs?
As weight loss drugs like Ozempic and Wegovy become more popular, obesity medicine specialists are concerned that not enough physicians have received specialized training to help patients navigate the medicine. Dr. Celine Gounder, CBS News medical contributor and editor-at-large for public health at KFF, has more on the situation.
Nestle to launch food products that cater to Wegovy and Ozempic users
Vital Pursuit will include whole-grain bowls, protein pasta, sandwich melts and gluten-free options.
High cost of drugs like Ozempic
Rising prices, insurance hurdles and a supply shortage can make access difficult for people who rely on drugs like Ozempic for diabetes and obesity, especially low-income patients. Renu Rayasam, senior correspondent with KFF Health News, joined CBS News to discuss the situation.
What is "oatzempic"? Experts weigh in on weight loss drink trend
Some claim "oatzempic," a drink that combines oats, water and lime juice, can help people drop weight fast — its name a nod to the popular weight loss drug Ozempic. Here's what experts say.
Using weight-loss drugs before pregnancy
Doctors are seeing more women turn to weight-loss drugs ahead of pregnancy. Studies show that being overweight can increase the chances of pregnancy complications, including miscarriages. And while the FDA does not authorize the use of weight loss medications during pregnancy, there is limited information on their effects before conception. Dr. Ilana Ramer Bass, an assistant professor in the division of endocrinology, diabetes and metabolism at Mount Sinai, joined CBS News to discuss the trend.
Doctors hopeful Ozempic, Wegovy may help treat alcohol addiction
Several clinical trials are underway to see if semaglutide, the active ingredient in weight loss drugs like Wegovy and Ozempic, can also help treat alcohol addiction.
Can Ozempic and Wegovy curb alcohol cravings?
Doctors are seeing a surprising possible side effect of weight loss drugs like Ozempic and Wegovy: a diminished craving for alcohol. Janet Shamlian reports.
New study on weight loss drug Wegovy
A new study published in the The New England Journal of Medicine by the maker of the popular weight loss drug Wegovy finds the medication could lower the risk of serious and even deadly heart problems by 20%. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS Mornings" to discuss.
How Ozempic, other weight-loss drugs are "changing medicine"
GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?
Possible Ozempic side effects, including hair loss, probed by FDA
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
How many calories should I burn a day? Your calorie questions, answered.
Calories can be confusing — but they don't have to be. We've got answers to your most-searched questions about calories.
Take the terror out of New Year's weight resolutions with the best home scales for 2024
We're weighing in on the best home scales in 2024.
Wellness trends to watch for in 2024: The Ozempic "ripple effect" and more
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
FDA issues warning about fake Ozempic
The Food and Drug Administration reports that it has seized thousands of units of counterfeit Ozempic, the popular diabetes medication that is also used for weight loss.
Poison centers see spike weight-loss drug calls
America's Poison Centers, a group that represents poison control centers across the U.S., reported a major spike in calls this year related to semaglutide, the main ingredient in weight loss drugs such as Ozempic and Wegovy.
Black patients have less access to anti-obesity drugs, data shows
According to data, while Black people are much more likely to suffer from obesity and diabetes, white people are four times more likely to get a prescription.
FDA approves new weight loss drug Zepbound
The FDA has approved Eli Lilly's Zepbound drug for weight loss. It's set to hit the market by the end of the year. Nancy Chen has more.
As Trump plans autism announcement, Tylenol maker and medical experts push back
Ahead of an expected announcement from the Trump administration linking Tylenol to autism risk, the drugmaker and medical experts are pushing back on the claims.
The night Jeffrey Epstein claimed his cellmate tried to kill him
New internal documents reveal details of an incident that left Jeffrey Epstein injured and on suicide watch days before his death.
White House shares plan to "save" TikTok, says Beijing agrees
"We feel confident that China has approved the deal," a senior White House official told reporters.
Sarah Ferguson dropped by U.K. charities over reported Epstein email
Newspapers in the U.K. published an email that Prince Andrew's ex-wife Sarah Ferguson reportedly wrote to the late convicted sex offender Jeffrey Epstein.
Parents navigate mixed messaging on child vaccine recommendations
Parents are navigating mixed messaging about childhood vaccinations from federal and state officials.
4 soldiers killed in Black Hawk helicopter crash identified by Army
Andrew Cully, Andrew Kraus, Donavon Scott and Jadalyn Good were part an elite team that does nighttime missions.
Maps show the forecast track of Hurricane Gabrielle
After growing into a hurricane, Gabrielle, the seventh named storm of the 2025 Atlantic hurricane season, is gaining steam, but is not expected to make landfall.
Bankrupt Spirit Airlines is furloughing one-third of its flight attendants
Spirit Airlines to furlough 1,800 flight attendants as budget carrier restructures, looks to cut costs.
Mamdani cancels appearance in WABC-TV town hall after Jimmy Kimmel suspension
Zohran Mamdani, the Democratic frontrunner in the race for New York City mayor, is pulling out of an upcoming town hall on WABC-TV.